Peripherally selective dopamine antagonists in the treatment of

Details Peripherally selective dopamine antagonists in the treatment of Peripherally selective dopamine antagonists in the treatment of

1983-10-31

1985-02-26

Robinson, Allen J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514320, 514324, 514913, A61K 3133, A61K 31445

Patent

active

045017492

ABSTRACT:
Peripherally selective dopamine antagonists are useful in the treatment of ocular hypertension when administered topically to the eye.

REFERENCES:
patent: 4370324 (1983-01-01), Bernstein
patent: 4412999 (1983-11-01), Remy et al.
Langham, "The Intraocular Pressure Response to .alpha. and .beta. Adrenergic Agonists in Normal and Glaucomatous Eyes", International Glaucoma Symposium (France), 1974.
Rosenbaum, "A Controlled Clinical Evaluation of Timolol in the Treatment of Patients with Elevated Intraocular Pressure", Glaucoma, vol. 1(1): 21-24, (1979).
Merck Index, 9th Edition, entry 6018, pp. 801-802, (1976).

Affiliated with

Also associated with

Rating

Peripherally selective dopamine antagonists in the treatment of does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peripherally selective dopamine antagonists in the treatment of , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peripherally selective dopamine antagonists in the treatment of will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-516489